Imagenetix Licenses Patent Related to Body Fat Control

Imagenetix Licenses Patent Related to Body Fat Control Company has announced that it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage.
Home Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Modern Science Confirms Ancient Wisdom! Modern Science Confirms Ancient Wisdom! "Natural" or "Plant-Derived" Labeling Can Mislead CDN: Natural Health Products Report - Update NPI Editorial: Are we using Best Practices? AHPA Update: Kava Information from the AHPA Executive Committee European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing Statement on Kava in New Zealand BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning Whole Foods Market Reports Fourth Quarter Results Company reports that sales increased 20% to $1.1 billion driven by 12% weighted average square footage growth and comparable store sales growth of 13.4%, as income before taxes was $25.0 million for the quarter. Allergy Research Group, Inc. Reports Sales for Third Quarter Company reports total revenue of $3,835,014 for the quarter, compared to $3,723,401 prior year, with net earnings of $244,274 as compared to net earnings of $354,336 for the same period in 2004. Allergy Research Group, Inc. Reports Sales for Third Quarter Company reports total revenue of $3,835,014 for the quarter, compared to $3,723,401 prior year, with net earnings of $244,274 as compared to net earnings of $354,336 for the same period in 2004. NutraCea Reports Third Quarter Results Company reports gross revenue of $301,726 in the third quarter of 2005 compared to $249,840 from the same quarter of 2004, with a net loss per share of $.03, compared to a net loss of $.04 per share, for the same period prior year. NutraCea Reports Third Quarter Results Company reports gross revenue of $301,726 in the third quarter of 2005 compared to $249,840 from the same quarter of 2004, with a net loss per share of $.03, compared to a net loss of $.04 per share, for the same period prior year. Forbes Medi-Tech Announces Third Quarter 2005 Financial Results Company reports revenues of $6.02 million for the three months compared to $5.37 million for the same three months prior year, with a net loss of $0.09 per share for the quarter, versus $0.05 per share loss for the three months prior year. Forbes Medi-Tech Announces Third Quarter 2005 Financial Results Company reports revenues of $6.02 million for the three months compared to $5.37 million for the same three months prior year, with a net loss of $0.09 per share for the quarter, versus $0.05 per share loss for the three months prior year. Galaxy Nutritional Foods Reports Second Quarter Operating Results Company reports net sales of approximately $10.4 million, compared with net sales of $11.9 million in the second quarter of the previous fiscal year, with a net loss to common stockholders of ($1,416,138), or ($0.07) per share, in the second quarter of FY2006, compared with restated net income to common stockholders of $410,389, or $0.03 per share, in the prior- year quarter. Galaxy Nutritional Foods Reports Second Quarter Operating Results Company reports net sales of approximately $10.4 million, compared with net sales of $11.9 million in the second quarter of the previous fiscal year, with a net loss to common stockholders of ($1,416,138), or ($0.07) per share, in the second quarter of FY2006, compared with restated net income to common stockholders of $410,389, or $0.03 per share, in the prior- year quarter. Natrol Announces Third Quarter Earnings Company reports net sales of $15.4 million compared to $20.9 million for the same qurter prior year, with a net loss of $742,000 or $0.05 per share, compared to net income of $384,000 or $0.03 per share, prior year. Natrol Announces Third Quarter Earnings Company reports net sales of $15.4 million compared to $20.9 million for the same qurter prior year, with a net loss of $742,000 or $0.05 per share, compared to net income of $384,000 or $0.03 per share, prior year. Lifeway Foods Reports Record Third Quarter, and Nine Months Sales Results Company reports sales of $5,194,648 compared to $4,138,606 during the same period a year ago, with earnings of $.07 per share for the third quarter 2005, compared to $.06 per share prior year. Lifeway Foods Reports Record Third Quarter, and Nine Months Sales Results Company reports sales of $5,194,648 compared to $4,138,606 during the same period a year ago, with earnings of $.07 per share for the third quarter 2005, compared to $.06 per share prior year. Leadership Changes in Strategic Business Units at Cognis Paul Allen, member of the Executive Committee and previously head of Cognis’ Nutrition & Health strategic business unit, has taken over as Group Vice President of Functional Products on November 1, 2005, and will remain President of Cognis Corporation, USA. His successor as head of Nutrition & Health will be Stéphane Baseden, previously Vice President of the Nutrition & Health business unit in Europe. Leadership Changes in Strategic Business Units at Cognis Paul Allen, member of the Executive Committee and previously head of Cognis’ Nutrition & Health strategic business unit, has taken over as Group Vice President of Functional Products on November 1, 2005, and will remain President of Cognis Corporation, USA. His successor as head of Nutrition & Health will be Stéphane Baseden, previously Vice President of the Nutrition & Health business unit in Europe. Leadership Changes in Strategic Business Units at Cognis Paul Allen, member of the Executive Committee and previously head of Cognis’ Nutrition & Health strategic business unit, has taken over as Group Vice President of Functional Products on November 1, 2005, and will remain President of Cognis Corporation, USA. His successor as head of Nutrition & Health will be Stéphane Baseden, previously Vice President of the Nutrition & Health business unit in Europe. Leadership Changes in Strategic Business Units at Cognis Paul Allen, member of the Executive Committee and previously head of Cognis’ Nutrition & Health strategic business unit, has taken over as Group Vice President of Functional Products on November 1, 2005, and will remain President of Cognis Corporation, USA. His successor as head of Nutrition & Health will be Stéphane Baseden, previously Vice President of the Nutrition & Health business unit in Europe. Makhteshim Agan Reports its Results for the Third Quarter of 2005 Company reports quarterly sales of $ 402.1 million compared to compared with $ 362.8 million prior year, with net profit for the quarter of $47.1 million with sales in North America increasing 34.6% to $56.7 million. The company reported that in the first nine months of the year, non-agro sales amounted to $ 151.7 million, an increase of 17.6%, mainly stemming from an increase in the sales of LycoRed. Makhteshim Agan Reports its Results for the Third Quarter of 2005 Company reports quarterly sales of $ 402.1 million compared to compared with $ 362.8 million prior year, with net profit for the quarter of $47.1 million with sales in North America increasing 34.6% to $56.7 million. The company reported that in the first nine months of the year, non-agro sales amounted to $ 151.7 million, an increase of 17.6%, mainly stemming from an increase in the sales of LycoRed. Lifeline Therapeutics Announces First Quarter Results Company reports Sales revenue for the quarter of $2,964,591, compared with no sales revenue for the same quarter in the prior fiscal year, with net income of $80,315 as it introduces its Protandim product. Lifeline Therapeutics Announces First Quarter Results Company reports Sales revenue for the quarter of $2,964,591, compared with no sales revenue for the same quarter in the prior fiscal year, with net income of $80,315 as it introduces its Protandim product. Homegrown Naturals Acquires Annie's Naturals, Leading Maker of All-Natural and Organic Salad Dressings Homegrown Naturals, Inc. has announced that it has acquired Annie's Naturals, the leading maker of all-natural and organic salad dressings and condiments. Solera Capital, LLC, the majority owner of Homegrown, facilitated the transaction through an investment in Homegrown, with finanical terms not disclosed. Homegrown Naturals Acquires Annie's Naturals, Leading Maker of All-Natural and Organic Salad Dressings Homegrown Naturals, Inc. has announced that it has acquired Annie's Naturals, the leading maker of all-natural and organic salad dressings and condiments. Solera Capital, LLC, the majority owner of Homegrown, facilitated the transaction through an investment in Homegrown, with finanical terms not disclosed. Homegrown Naturals Acquires Annie's Naturals, Leading Maker of All-Natural and Organic Salad Dressings Homegrown Naturals, Inc. has announced that it has acquired Annie's Naturals, the leading maker of all-natural and organic salad dressings and condiments. Solera Capital, LLC, the majority owner of Homegrown, facilitated the transaction through an investment in Homegrown, with finanical terms not disclosed. Homegrown Naturals Acquires Annie's Naturals, Leading Maker of All-Natural and Organic Salad Dressings Homegrown Naturals, Inc. has announced that it has acquired Annie's Naturals, the leading maker of all-natural and organic salad dressings and condiments. Solera Capital, LLC, the majority owner of Homegrown, facilitated the transaction through an investment in Homegrown, with finanical terms not disclosed. Natural Health Trends Corp. Promotes Paul Rogers to President of Lexxus Division Company announces that it has promoted Paul Rogers to the newly created position of President of Lexxus International from Vice President of Sales and Marketing responsible for distributor-base growth and international expansion. Natural Health Trends Corp. Promotes Paul Rogers to President of Lexxus Division Company announces that it has promoted Paul Rogers to the newly created position of President of Lexxus International from Vice President of Sales and Marketing responsible for distributor-base growth and international expansion. Natural Health Trends Corp. Promotes Paul Rogers to President of Lexxus Division Company announces that it has promoted Paul Rogers to the newly created position of President of Lexxus International from Vice President of Sales and Marketing responsible for distributor-base growth and international expansion. Natural Health Trends Corp. Promotes Paul Rogers to President of Lexxus Division Company announces that it has promoted Paul Rogers to the newly created position of President of Lexxus International from Vice President of Sales and Marketing responsible for distributor-base growth and international expansion. PacificHealth Laboratories, Inc. Announces 3rd Quarter Results Company reports revenues were $1.67 million compared to $1.89 million in the same period in 2004, with a net loss of ($154,959), or ($0.02) per basic and fully diluted share compared to a net loss of ($303,343), or ($0.03) per basic and fully diluted share for the same period in 2004. PacificHealth Laboratories, Inc. Announces 3rd Quarter Results Company reports revenues were $1.67 million compared to $1.89 million in the same period in 2004, with a net loss of ($154,959), or ($0.02) per basic and fully diluted share compared to a net loss of ($303,343), or ($0.03) per basic and fully diluted share for the same period in 2004. Cory J. Comstock Joins Sherbrooke Capital as Operating Partner Company announces appointment of Cory J. Comstock as an Operating Partner. Cory Comstock has broad operational experience with premium branded companies, having held a variety of sales, marketing and operational positions with PowerBar, Odwalla, and most recently Oregon Chai, Inc., where he served as CEO. Cory J. Comstock Joins Sherbrooke Capital as Operating Partner Company announces appointment of Cory J. Comstock as an Operating Partner. Cory Comstock has broad operational experience with premium branded companies, having held a variety of sales, marketing and operational positions with PowerBar, Odwalla, and most recently Oregon Chai, Inc., where he served as CEO. Cory J. Comstock Joins Sherbrooke Capital as Operating Partner Company announces appointment of Cory J. Comstock as an Operating Partner. Cory Comstock has broad operational experience with premium branded companies, having held a variety of sales, marketing and operational positions with PowerBar, Odwalla, and most recently Oregon Chai, Inc., where he served as CEO. Cory J. Comstock Joins Sherbrooke Capital as Operating Partner Company announces appointment of Cory J. Comstock as an Operating Partner. Cory Comstock has broad operational experience with premium branded companies, having held a variety of sales, marketing and operational positions with PowerBar, Odwalla, and most recently Oregon Chai, Inc., where he served as CEO. Synutra Reports Second Quarter Performance Company reports net income of $1.9 million for the second quarter on sales of $25.8 million as compared to $13 million for the same three months in 2004, earning $.04 per share in the second quarter, versus a loss of $.03 in the prior year's period. Synutra Reports Second Quarter Performance Company reports net income of $1.9 million for the second quarter on sales of $25.8 million as compared to $13 million for the same three months in 2004, earning $.04 per share in the second quarter, versus a loss of $.03 in the prior year's period. Zila to Introduce Ester-C(R) Advanced Vitamin C into Japan; Asahi Godo Signs Distributor Agreement Zila Nutraceuticals, Inc., has signed an agreement with Asahi Godo to distribute its Ester-C(R) advanced vitamin C ingredient in Japan; companies to work together to attain Japanese regulatory approval in order to allow the sale of Ester-C(R), considered a food additive in Japan, in vitamin and dietary supplement products as well as foods and beverages. Zila to Introduce Ester-C(R) Advanced Vitamin C into Japan; Asahi Godo Signs Distributor Agreement Zila Nutraceuticals, Inc., has signed an agreement with Asahi Godo to distribute its Ester-C(R) advanced vitamin C ingredient in Japan; companies to work together to attain Japanese regulatory approval in order to allow the sale of Ester-C(R), considered a food additive in Japan, in vitamin and dietary supplement products as well as foods and beverages. Zila to Introduce Ester-C(R) Advanced Vitamin C into Japan; Asahi Godo Signs Distributor Agreement Zila Nutraceuticals, Inc., has signed an agreement with Asahi Godo to distribute its Ester-C(R) advanced vitamin C ingredient in Japan; companies to work together to attain Japanese regulatory approval in order to allow the sale of Ester-C(R), considered a food additive in Japan, in vitamin and dietary supplement products as well as foods and beverages. Zila to Introduce Ester-C(R) Advanced Vitamin C into Japan; Asahi Godo Signs Distributor Agreement Zila Nutraceuticals, Inc., has signed an agreement with Asahi Godo to distribute its Ester-C(R) advanced vitamin C ingredient in Japan; companies to work together to attain Japanese regulatory approval in order to allow the sale of Ester-C(R), considered a food additive in Japan, in vitamin and dietary supplement products as well as foods and beverages. Royal BodyCare Announces Korean Expansion Company announces the formation of a wholly owned subsidiary, RBC Life Sciences Korea Ltd., in Seoul, South Korea with new branch to begin sales of RBC nutritional supplements in January, 2006. Royal BodyCare Announces Korean Expansion Company announces the formation of a wholly owned subsidiary, RBC Life Sciences Korea Ltd., in Seoul, South Korea with new branch to begin sales of RBC nutritional supplements in January, 2006. AMS Health Sciences, Inc. Announces Third Quarter 2005 Financial Results Company reports sales for the first nine months of 2005 totaled $10.4 million compared to $13.3 million for the same period prior year.Net loss for the first nine months of 2005 was $2,621,737, or ($0.36) per common (diluted) share, compared to a net loss of $1,909,963, or ($0.28) per common (diluted) share prior year. AMS Health Sciences, Inc. Announces Third Quarter 2005 Financial Results Company reports sales for the first nine months of 2005 totaled $10.4 million compared to $13.3 million for the same period prior year.Net loss for the first nine months of 2005 was $2,621,737, or ($0.36) per common (diluted) share, compared to a net loss of $1,909,963, or ($0.28) per common (diluted) share prior year. Frutarom Reports Third Quarter Sales Results Company reports sales of US$ 59.4 million, a 15.6% increase compared with the same quarter of 2004, while gross profit for the third quarter of 2005 rose 18.3% to reach US$ 23 million compared with US$ 19.5 million in the same quarter last year. Frutarom Reports Third Quarter Sales Results Company reports sales of US$ 59.4 million, a 15.6% increase compared with the same quarter of 2004, while gross profit for the third quarter of 2005 rose 18.3% to reach US$ 23 million compared with US$ 19.5 million in the same quarter last year. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. Solbar Restructures for New Challenges Company restructures into two divisions with Assaf Gadish assuming responsibilities for the Commodities Soy division and Gidi Landsberger to lead Solbar's Specialty Products Division. BioEnvelop signs exclusive agreement to produce edible film for NuitriCorp, division of Jamieson Laboratories Company announces announce that it has entered into an exclusive agreement to manufacture nutraceutical film products for NutriCorp International, a wholly owned division of Jamieson Laboratories. BioEnvelop signs exclusive agreement to produce edible film for NuitriCorp, division of Jamieson Laboratories Company announces announce that it has entered into an exclusive agreement to manufacture nutraceutical film products for NutriCorp International, a wholly owned division of Jamieson Laboratories. BioEnvelop signs exclusive agreement to produce edible film for NuitriCorp, division of Jamieson Laboratories Company announces announce that it has entered into an exclusive agreement to manufacture nutraceutical film products for NutriCorp International, a wholly owned division of Jamieson Laboratories. BioEnvelop signs exclusive agreement to produce edible film for NuitriCorp, division of Jamieson Laboratories Company announces announce that it has entered into an exclusive agreement to manufacture nutraceutical film products for NutriCorp International, a wholly owned division of Jamieson Laboratories. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. Novartis Announces the Successful Divestment of its Nutrition & Santé Unit Company has signed a definitive agreement to divest its Nutrition & Santé business unit to ABN AMRO Capital France for approximately EUR 220 million (USD 260 million) on a cash and debt free basis. ADM Names Doug Millar Vice President-Product and Market Development Doug Millar has been named Vice President-Product and Market Development for the Corn Processing, Natural Health and Nutrition, and Specialty Food Ingredients divisions of Archer Daniels Midland Company. ADM Names Doug Millar Vice President-Product and Market Development Doug Millar has been named Vice President-Product and Market Development for the Corn Processing, Natural Health and Nutrition, and Specialty Food Ingredients divisions of Archer Daniels Midland Company. ADM Names Doug Millar Vice President-Product and Market Development Doug Millar has been named Vice President-Product and Market Development for the Corn Processing, Natural Health and Nutrition, and Specialty Food Ingredients divisions of Archer Daniels Midland Company. ADM Names Doug Millar Vice President-Product and Market Development Doug Millar has been named Vice President-Product and Market Development for the Corn Processing, Natural Health and Nutrition, and Specialty Food Ingredients divisions of Archer Daniels Midland Company. Neptune Progresses in its European Market Penetration of Neptune Krill Oil Company announces that Neptune Krill Oil and its Logo and Trademark have been approved and registered by the European Registration Office. Neptune Progresses in its European Market Penetration of Neptune Krill Oil Company announces that Neptune Krill Oil and its Logo and Trademark have been approved and registered by the European Registration Office. Saw Palmetto Berries Co-op Fights Allegations Company President Gregory Zaino notes that "Prices fluctuate with environmental climate, events, labor and crop volume, not by some fictitious cartel..." Saw Palmetto Berries Co-op Fights Allegations Company President Gregory Zaino notes that "Prices fluctuate with environmental climate, events, labor and crop volume, not by some fictitious cartel..." Natural Health Trends Corp. Announces Additional Investment In China Company has invested an additional $10 million cash into its Chinese subsidiary, as it prepares to meet new Chinese requirements to qualify for the capital requirements as set forth in China's Direct Selling Laws, expected to be adopted on December 1, 2005. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	SAN DIEGO, Nov 16, 2005 (BUSINESS WIRE) -- Imagenetix, Inc. (IAGX), an innovator of scientifically tested, natural-based, proprietary bioceutical products that enhance human health, today announced it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage. The compound, branded as Lepitrim(TM), will be marketed immediately by Imagenetix and its distribution partners across the U.S. and Canada. Product revenue to Imagenetix during the first 12 months is expected to be between $10 and $15 million, said the company. Lepitrim(TM) is not a drug, but is comprised of natural polysaccharide compounds which have been found in animal studies conducted at the University of Minnesota to lower serum leptin levels and reduce stored body fat with no side effects. Imagenetix CEO William P. Spencer said: "We are very excited about the results of recent research on the role of leptin in fat utilization and regulation. We believe that Lepitrim(TM) will provide immediate and longer term assistance to the countless number of individuals that have tried and failed to lose body fat using other weight management programs. "We have therefore begun to initiate comprehensive distribution and marketing strategies for Lepitrim(TM) with our marketing partners and are optimistic the product will carve out a significant market niche for years to come." According to the National Center for Health Statistics, 65 percent of Americans are either overweight or obese. In 2004, nearly $150 billion was spent in the U.S. on obesity-related products. Imagenetix, Inc. (IAGX), www.imagenetix.net, develops, formulates, private-labels, and produces nutritional supplements, over-the-counter topical creams, skin care products and pharmaceuticals for inflammatory-related markets. Safe Harbor Statement This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements. The company may experience significant fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, the size and timing of customer contracts, new or increased competition, changes in market demand, and seasonality of purchases of the company's products and services. These factors and others could cause operating results to vary significantly from those in prior periods and those projected in forward-looking statements. Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in certain forms the company expects to file with the Securities Exchange Commission.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software